시장보고서

상품코드

1558421

해부 병리학 시장 규모 및 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 : 제품 및 서비스별, 용도별, 최종사용자별, 지역별

Anatomic Pathology Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product and Services, Application, End User, and Geography

발행일: 2024년 08월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 178 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

폐사 새로운 조사 리포트 ' 해부 병리학 시장의 2031년까지 예측-세계의 분석 - 제품·서비스, 용도, 최종사용자, 지역별 '에 따르면 이 시장 규모는 2023년 302억 2,000만 달러에서 성장하며, 2031년에는 532억 7,000만 달러에 달할 것으로 예측되고 있으며, 2023-2031년에 CAGR 7.3%를 기록할 전망입니다. 암과 신장질환의 유병률 증가와 전략적 구상 증가는 해부 병리학 시장의 성장에 기여하고 있습니다. 그러나 숙련된 전문가 부족과 정부의 엄격한 규제가 시장 성장을 저해하는 요인으로 작용하고 있습니다. 또한 인공지능과 머신러닝의 통합은 향후 수년간 해부 병리학 시장의 새로운 동향을 가져올 것으로 예상됩니다.

해부 병리학은 장기나 조직을 연구하여 특정 질병의 원인과 영향을 밝히는 학문입니다. 해부 병리학은 신체 장기의 구조에 대한 질병의 영향을 전체적(육안적)으로 또는 현미경적으로 연구하는 의학의 한 분야입니다. 해부 병리학의 주요 역할은 질병의 진단과 치료 관리에 도움이 되는 이상을 확인하는 것입니다. 해부 병리학은 다양한 유형의 종양과 암을 식별하고 관리하는 데 도움이 되는 경우가 많지만, 신장 및 간 질환, 자가면역 질환, 감염성 질환 등 다른 질환을 평가하는 데도 유용합니다.

2023년 세계 해부 병리학 시장에서 북미가 큰 비중을 차지할 것으로 예상됩니다. 북미 해부 병리학 시장은 미국, 캐나다, 멕시코로 구분됩니다.

미국에서는 암이 사회에 큰 영향을 미치고 있습니다. 미국에서 흔히 발생하는 암은 유방암, 폐암, 기관지암, 전립선암, 대장암, 직장암, 간암 등입니다. 암 생존자 수는 2030년까지 2,220만 명에 달할 것으로 예측됩니다. 이러한 암 환자 증가는 생검, 세침흡인(FNA), 유전자 검사 및 기타 새로운 기술과 같은 병리 진단 검사에 대한 수요를 증가시킬 것으로 예상됩니다. 또한 미국에서는 최근 수년간 혁신적이고 개선된 의료 기술이 그 어느 때보다 빠르게 성장하고 있습니다. 이러한 성장은 헬스케어 산업에서 첨단 의료기기의 개발로 이어졌습니다. 2023년 11월, DNA 시퀀싱 및 어레이 기반 기술의 세계 리더인 미국 일루미나(Illumina)는 조직 기반 검사를 보완하고 혈액에서 순환하는 종양 DNA의 종합적인 비침습적 비침습적 검사에 대한 새로운 기술을 개발했습니다. 종양 DNA의 종합적인 비침습적 유전체 프로파일링을 가능하게 하는 분산형 액체생검 분석의 새로운 버전인 TruSight Oncology 500 ctDNA v2(플레이트 번호 1 ctDNA v2)를 발표했습니다. 미국 식품의약국(FDA)으로부터 임상의의 자궁경부암 예방에 도움을 주는 CINtec PLUS 세포진 검사에 대한 사용 확대 승인을 받았습니다. 이처럼 높은 암 유병률, 대기업의 존재감, 병원 및 임상 실험실의 수준 높은 인프라 등이 미국 해부병리 시장의 성장을 촉진하고 있습니다.

정부와 민간 농업 단체들은 작물의 특성을 개선하기 위해 작물 유전체학의 발전에 큰 관심을 기울이고 있으며, National Institute of Food and Agriculture의 Agricultural Genome to Phenome Initiative(AG2 PI)는 작물과 동물의 유전학을 연구하는 연구자 커뮤니티를 발전시키기 위한 공동 작업에 중점을 두고 있으며, 이는 미국 농업 부문에 중요한 유전체과 페놈에 대한 지식을 확대하기 위한 토대를 마련할 것입니다. 이 구상은 날씨, 환경 및 생산 시스템의 변화가 작물과 동물의 유전적 다양성에 어떤 영향을 미치는지 이해하기 위한 접근법을 개발하는 데 도움이 될 것으로 보입니다. 이처럼 수확량 및 품질 향상을 위한 작물의 유전적 구성과 관련된 연구를 촉진하기 위한 노력이 증가하고 있는 것은 향후 미국 해부 병리학 시장에 유리하게 작용할 가능성이 높습니다.

맞춤형 의료에 대한 관심이 높아지면서 향후 시장 기회로 이어질 것입니다.

맞춤형 의료는 주로 개인의 유전자 프로파일을 고려하여 설계되며, 질병 예방, 진단 및 치료와 관련된 의사결정의 지침이 될 수 있습니다. 제약회사에게는 약물이 의도한 대로 효과가 없는 환자군이나 기존 의료서비스가 기대한 만큼의 효과를 얻지 못하는 환자군을 타깃으로 하는 약물을 개발할 수 있는 기회를 제공합니다. 약물 반응의 상당 부분이 연령, 영양 상태, 환경 노출, 건강 상태 등 유전적으로 조절되는 요인에 따라 달라진다는 많은 증거가 있습니다. 유전체학은 맞춤형 의료의 출현에 중요한 역할을 하고 있습니다. 환자의 유전자 프로파일을 알면 의사가 적절한 약물을 선택하는 데 도움이 되기 때문입니다. 맞춤형 의료는 각 환자가 더 빨리 진단, 위험 평가 및 최적의 치료를 받을 수 있도록 함으로써 의료 서비스를 개선하는 데 도움이 될 수 있습니다.

병리학자들은 분자검사와 게놈 검사의 개발 및 실행에 있으며, 중요한 역할을 하고 있습니다. 맞춤형 항암제는 유방암, 심혈관 질환 등의 치료에 사용되고 있습니다. 맞춤형 항암제는 보다 특이적으로 작용하도록 설계되어 다른 치료법보다 부작용이 적고 심각한 부작용이 적습니다. 또한 연구와 임상 연구가 진행됨에 따라 맞춤형 항암제는 환자 치료의 질을 향상시킬 수 있는 가능성이 더욱 높아지고 있습니다. 이처럼 맞춤의료에 대한 관심이 높아지면서 해부 병리학 시장의 성장을 촉진할 것으로 예상됩니다.

해부 병리학 시장 경쟁 구도와 주요 발전

F.Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, BD, PHC Holdings Corporation 등이 해부 병리학 시장에서 사업을 운영하는 주요 기업입니다.

미국 식품의약국, 질병통제예방센터(CDC), 경제협력개발기구(OECD) 등은 해부 병리학 시장 보고서를 작성할 때 참고한 1차 정보 및 2차 정보 중 하나입니다.

해부 병리학 시장 - 주요 시장 역학
시장 성장 촉진요인
- 암과 신장병의 증가
- 전략적 구상의 증가
시장 성장 억제요인
- 숙련 전문가의 부족
- 엄격한 정부 규제
시장 기회
- 맞춤형 의료에 대한 주목의 증가
향후 동향
- 인공지능과 기계학습의 통합
촉진요인과 억제요인의 영향

제6장 해부 병리학 시장 : 세계 시장 분석

해부 병리학 시장 매출(2021-2031년)
해부 병리학 시장 예측 분석

제7장 해부 병리학 시장의 분석 - 제품·서비스별

서비스
기구
소모품

제8장 해부 병리학 시장의 분석 - 용도별

질병 진단
Drug Discovery·의약품 개발
기타

제9장 해부 병리학 시장의 분석 - 최종사용자별

병원
연구기관
진단 연구소
기타

제10장 해부 병리학 시장 - 지역별 분석

북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 기타 아시아태평양
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 기타 중동 및 아프리카
중남미
- 브라질
- 아르헨티나
- 기타 중남미

제11장 업계 상황

해부 병리학 시장의 성장 전략
유기적 성장 전략
무기적 성장 전략

제12장 기업 개요

F. Hoffmann-La Roche Ltd
Beckman Coulter Inc
Hologic Inc
Agilent Technologies Inc
BioGenex Laboratories Inc
Diapath S.p.A.
Bio SB
Merck KGaA
PHC Holdings Corporation

제13장 부록

KSA 24.10.16

According to our new research study on "Anatomic Pathology Market Forecast to 2031 - Global Analysis - by Products and Services, Application, End User, and Geography," the market is anticipated to grow from US$ 30.22 billion in 2023 and is projected to reach US$ 53.27 billion by 2031; it is expected to register a CAGR of 7.3% during 2023-2031. The increase in the prevalence of cancer and kidney diseases and the rise in the number of strategic initiatives are contributing to the anatomic pathology market growth. However, the shortage of skilled professionals and stringent government regulations hamper the market growth. Further, the integration of artificial intelligence and machine learning is expected to bring new anatomic pathology market trends in the coming years.

Anatomical pathology is the study of organs and tissues to determine the causes and effects of particular diseases. Anatomic (or anatomical) pathology is the branch of medicine that studies the effect of disease on the structure of body organs, both as a whole (grossly) and microscopically. The primary role of anatomic pathology is to identify abnormalities that can help to diagnose disease and manage treatment. Although one of the frequent uses of anatomic pathology is to help identify and manage various types of tumors or cancers, it is also valuable in evaluating other conditions, including kidney and liver diseases, autoimmune disorders, and infections, for example.

North America accounted for a major share of the global anatomic pathology market in 2023. The North America anatomic pathology market is segmented into the US, Canada, and Mexico.

In the US, cancer has a significant impact on society. A few common cancer types in the country are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, and liver cancer. As per the National Cancer Institute, in 2021, ~17.43 individuals were living with cancer at any site in the US. The number of cancer survivors is projected to reach 22.2 million by 2030. This mounting prevalence of cancer cases is expected to increase the demand for pathologic diagnostic tests such as biopsies, fine-needle aspiration (FNA), genetic testing, and other novel techniques. Moreover, there has been unprecedented growth in innovative and improved medical technologies in the US in recent years. This growth resulted in the development of advanced medical devices in the healthcare industry. Players operating in the US anatomic pathology market continuously focus on the development of innovative and convenient instruments and consumables for pathological procedures. In November 2023, Illumina Inc., US, a global leader in DNA sequencing and array-based technologies, introduced TruSight Oncology 500 ctDNA v2 (plate number 1 ctDNA v2), a new version of its distributed liquid biopsy assay that allows comprehensive noninvasive genomic profiling of circulating tumor DNA from blood, complementing tissue-based testing. In 2020, F. Hoffmann-La Roche received the US Food and Drug Administration (FDA) approval for the expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer. Thus, factors such as the high prevalence of cancer, strong presence of some major players, and availability of high-quality infrastructure for hospitals and clinical laboratories bolster the growth of the anatomic pathology market in the US.

Governments and private agricultural associations are highly focused on advancements in crop genomics to improve the characteristics of crops. The Agricultural Genome to Phenome Initiative (AG2PI) of the National Institute of Food and Agriculture focuses on collaborative engagements to develop a community of researchers studying both crop and animal genetics, which would lay the foundation for expanding knowledge about genomes and phenomes that are important to the agriculture sector in the US. The initiative is likely to result in the development of approaches to understanding how variable weather, environments, and production systems impact genetic diversity in crops and animals. Thus, the rising number of initiatives taken to foster studies related to the genetic makeup of crops for yield and quality improvement are likely to favor the anatomic pathology market in the US in the future.

Growing Focus on Personalized Medicines to Provide Market Opportunities in Future

Personalized medicines are mainly designed by considering individuals' genetic profiles to guide the decisions made with respect to the prevention, diagnosis, and treatment of a disease. They provide an opportunity for drug manufacturers to develop agents that target patient groups that do not respond to medications as intended or for them who do not respond as expected to traditional healthcare practices. There is much evidence indicating that a substantial portion of the variability in drug response depends on factors that are genetically controlled, including age, nutrition, environmental exposure, and health status. Genomics plays an important role in the emergence of personalized medicines, as having the knowledge of a patient's genetic profile would help doctors in selecting an apt medication. Personalized medicines are helpful in improving healthcare by enabling each patient to receive earlier diagnoses, risk assessments, and optimal treatments.

Pathologists play an important role in developing and implementing molecular and genomic tests in practice. Personalized medicines are used in the treatment of diseases such as breast cancer and cardiovascular diseases. Personalized anticancer medicines exhibit fewer and less severe side effects than other types of treatment as they are designed for more specific action. Further, with the ongoing progress in research and clinical studies, personalized medicines are likely to reach even greater potential to improve the quality of patient care. Thus, the growing focus on personalized medicines is expected to boost the anatomic pathology market growth.

Anatomic Pathology Market: Competitive Landscape and Key Developments

F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, BD, and PHC Holdings Corporation are among the key companies operating in the anatomic pathology market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Organisation for Economic Co-operation and Development are among the primary and secondary sources referred to while preparing the anatomic pathology market report.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Anatomic Pathology Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Anatomic Pathology Market - Key Market Dynamics

5.1 Anatomic Pathology Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increase in Prevalence of Cancer and Kidney Diseases
- 5.2.2 Rise in Number of Strategic Initiatives
5.3 Market Restraints
- 5.3.1 Lack of Skilled Professionals
- 5.3.2 Stringent Government Regulations
5.4 Market Opportunities
- 5.4.1 Growing Focus on Personalized Medicines
5.5 Future Trends
- 5.5.1 Integration of Artificial Intelligence and Machine Learning
5.6 Impact of Drivers and Restraints:

6. Anatomic Pathology Market - Global Market Analysis

6.1 Anatomic Pathology Market Revenue (US$ Million), 2021-2031
6.2 Anatomic Pathology Market Forecast Analysis

7. Anatomic Pathology Market Analysis - by Product and Services

7.1 Services
- 7.1.1 Overview
- 7.1.2 Services: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Consumables
- 7.3.1 Overview
- 7.3.2 Consumables: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

8. Anatomic Pathology Market Analysis - by Application

8.1 Disease Diagnosis
- 8.1.1 Overview
- 8.1.2 Disease Diagnosis: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Drug Discovery and Development
- 8.2.1 Overview
- 8.2.2 Drug Discovery and Development: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

9. Anatomic Pathology Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Research Laboratories: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Diagnostic Laboratories: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

10. Anatomic Pathology Market - Geographical Analysis

10.1 Overview
10.2 North America
- 10.2.1 North America Anatomic Pathology Market Overview
- 10.2.2 North America: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2.3 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
- 10.2.4 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
- 10.2.5 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
- 10.2.6 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
- 10.2.7 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
- 10.2.8 North America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.2.8.1 United States: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.8.1.1 United States: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.2.8.1.1.1 United States: Anatomic Pathology Market Breakdown, by Services
    - 10.2.8.1.1.2 United States: Anatomic Pathology Market Breakdown, by Instruments
    - 10.2.8.1.2 United States: Anatomic Pathology Market Breakdown, by Application
    - 10.2.8.1.3 United States: Anatomic Pathology Market Breakdown, by End User
  - 10.2.8.2 Canada: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.8.2.1 Canada: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.2.8.2.1.1 Canada: Anatomic Pathology Market Breakdown, by Services
    - 10.2.8.2.1.2 Canada: Anatomic Pathology Market Breakdown, by Instruments
    - 10.2.8.2.2 Canada: Anatomic Pathology Market Breakdown, by Application
    - 10.2.8.2.3 Canada: Anatomic Pathology Market Breakdown, by End User
  - 10.2.8.3 Mexico: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.8.3.1 Mexico: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.2.8.3.1.1 Mexico: Anatomic Pathology Market Breakdown, by Services
    - 10.2.8.3.1.2 Mexico: Anatomic Pathology Market Breakdown, by Instruments
    - 10.2.8.3.2 Mexico: Anatomic Pathology Market Breakdown, by Application
    - 10.2.8.3.3 Mexico: Anatomic Pathology Market Breakdown, by End User
10.3 Europe
- 10.3.1 Europe Anatomic Pathology Market Overview
- 10.3.2 Europe: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.3 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
- 10.3.4 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
- 10.3.5 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
- 10.3.6 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
- 10.3.7 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
- 10.3.8 Europe: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.3.8.1 United Kingdom: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.8.1.1 United Kingdom: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.3.8.1.1.1 United Kingdom: Anatomic Pathology Market Breakdown, by Services
    - 10.3.8.1.1.2 United Kingdom: Anatomic Pathology Market Breakdown, by Instruments
    - 10.3.8.1.2 United Kingdom: Anatomic Pathology Market Breakdown, by Application
    - 10.3.8.1.3 United Kingdom: Anatomic Pathology Market Breakdown, by End User
  - 10.3.8.2 Germany: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.8.2.1 Germany: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.3.8.2.1.1 Germany: Anatomic Pathology Market Breakdown, by Services
    - 10.3.8.2.1.2 Germany: Anatomic Pathology Market Breakdown, by Instruments
    - 10.3.8.2.2 Germany: Anatomic Pathology Market Breakdown, by Application
    - 10.3.8.2.3 Germany: Anatomic Pathology Market Breakdown, by End User
  - 10.3.8.3 France: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.8.3.1 France: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.3.8.3.1.1 France: Anatomic Pathology Market Breakdown, by Services
    - 10.3.8.3.1.2 rance: Anatomic Pathology Market Breakdown, by Instruments
    - 10.3.8.3.2 France: Anatomic Pathology Market Breakdown, by Application
    - 10.3.8.3.3 France: Anatomic Pathology Market Breakdown, by End User
  - 10.3.8.4 Italy: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.8.4.1 Italy: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.3.8.4.1.1 Italy: Anatomic Pathology Market Breakdown, by Services
    - 10.3.8.4.1.2 Italy: Anatomic Pathology Market Breakdown, by Instruments
    - 10.3.8.4.2 Italy: Anatomic Pathology Market Breakdown, by Application
    - 10.3.8.4.3 Italy: Anatomic Pathology Market Breakdown, by End User
  - 10.3.8.5 Spain: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.8.5.1 Spain: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.3.8.5.1.1 Spain: Anatomic Pathology Market Breakdown, by Services
    - 10.3.8.5.1.2 Spain: Anatomic Pathology Market Breakdown, by Instruments
    - 10.3.8.5.2 Spain: Anatomic Pathology Market Breakdown, by Application
    - 10.3.8.5.3 Spain: Anatomic Pathology Market Breakdown, by End User
  - 10.3.8.6 Rest of Europe: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.8.6.1 Rest of Europe: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.3.8.6.1.1 Rest of Europe: Anatomic Pathology Market Breakdown, by Services
    - 10.3.8.6.1.2 Rest of Europe: Anatomic Pathology Market Breakdown, by Instruments
    - 10.3.8.6.2 Rest of Europe: Anatomic Pathology Market Breakdown, by Application
    - 10.3.8.6.3 Rest of Europe: Anatomic Pathology Market Breakdown, by End User
10.4 Asia Pacific
- 10.4.1 Asia Pacific Anatomic Pathology Market Overview
- 10.4.2 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.3 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
- 10.4.4 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
- 10.4.5 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
- 10.4.6 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
- 10.4.7 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
- 10.4.8 Asia Pacific: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.4.8.1 China: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.8.1.1 China: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.4.8.1.1.1 China: Anatomic Pathology Market Breakdown, by Services
    - 10.4.8.1.1.2 China: Anatomic Pathology Market Breakdown, by Instruments
    - 10.4.8.1.2 China: Anatomic Pathology Market Breakdown, by Application
    - 10.4.8.1.3 China: Anatomic Pathology Market Breakdown, by End User
  - 10.4.8.2 Japan: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.8.2.1 Japan: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.4.8.2.1.1 Japan: Anatomic Pathology Market Breakdown, by Services
    - 10.4.8.2.1.2 Japan: Anatomic Pathology Market Breakdown, by Instruments
    - 10.4.8.2.2 Japan: Anatomic Pathology Market Breakdown, by Application
    - 10.4.8.2.3 Japan: Anatomic Pathology Market Breakdown, by End User
  - 10.4.8.3 India: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.8.3.1 India: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.4.8.3.1.1 India: Anatomic Pathology Market Breakdown, by Services
    - 10.4.8.3.1.2 India: Anatomic Pathology Market Breakdown, by Instruments
    - 10.4.8.3.2 India: Anatomic Pathology Market Breakdown, by Application
    - 10.4.8.3.3 India: Anatomic Pathology Market Breakdown, by End User
  - 10.4.8.4 Australia: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.8.4.1 Australia: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.4.8.4.1.1 Australia: Anatomic Pathology Market Breakdown, by Services
    - 10.4.8.4.1.2 Australia: Anatomic Pathology Market Breakdown, by Instruments
    - 10.4.8.4.2 Australia: Anatomic Pathology Market Breakdown, by Application
    - 10.4.8.4.3 Australia: Anatomic Pathology Market Breakdown, by End User
  - 10.4.8.5 South Korea: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.8.5.1 South Korea: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.4.8.5.1.1 South Korea: Anatomic Pathology Market Breakdown, by Services
    - 10.4.8.5.1.2 South Korea: Anatomic Pathology Market Breakdown, by Instruments
    - 10.4.8.5.2 South Korea: Anatomic Pathology Market Breakdown, by Application
    - 10.4.8.5.3 South Korea: Anatomic Pathology Market Breakdown, by End User
  - 10.4.8.6 Rest of APAC: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.8.6.1 Rest of APAC: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.4.8.6.1.1 Rest of APAC: Anatomic Pathology Market Breakdown, by Services
    - 10.4.8.6.1.2 Rest of APAC: Anatomic Pathology Market Breakdown, by Instruments
    - 10.4.8.6.2 Rest of APAC: Anatomic Pathology Market Breakdown, by Application
    - 10.4.8.6.3 Rest of APAC: Anatomic Pathology Market Breakdown, by End User
10.5 Middle East and Africa
- 10.5.1 Middle East and Africa Anatomic Pathology Market Overview
- 10.5.2 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5.3 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
- 10.5.4 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
- 10.5.5 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
- 10.5.6 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
- 10.5.7 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
- 10.5.8 Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.5.8.1 South Africa: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.8.1.1 South Africa: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.5.8.1.1.1 South Africa: Anatomic Pathology Market Breakdown, by Services
    - 10.5.8.1.1.2 South Africa: Anatomic Pathology Market Breakdown, by Instruments
    - 10.5.8.1.2 South Africa: Anatomic Pathology Market Breakdown, by Application
    - 10.5.8.1.3 South Africa: Anatomic Pathology Market Breakdown, by End User
  - 10.5.8.2 Saudi Arabia: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.8.2.1 Saudi Arabia: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.5.8.2.1.1 Saudi Arabia: Anatomic Pathology Market Breakdown, by Services
    - 10.5.8.2.1.2 Saudi Arabia: Anatomic Pathology Market Breakdown, by Instruments
    - 10.5.8.2.2 Saudi Arabia: Anatomic Pathology Market Breakdown, by Application
    - 10.5.8.2.3 Saudi Arabia: Anatomic Pathology Market Breakdown, by End User
  - 10.5.8.3 United Arab Emirates: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.8.3.1 United Arab Emirates: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.5.8.3.1.1 United Arab Emirates: Anatomic Pathology Market Breakdown, by Services
    - 10.5.8.3.1.2 United Arab Emirates: Anatomic Pathology Market Breakdown, by Instruments
    - 10.5.8.3.2 United Arab Emirates: Anatomic Pathology Market Breakdown, by Application
    - 10.5.8.3.3 United Arab Emirates: Anatomic Pathology Market Breakdown, by End User
  - 10.5.8.4 Rest of Middle East and Africa: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.8.4.1 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.5.8.4.1.1 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Services
    - 10.5.8.4.1.2 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Instruments
    - 10.5.8.4.2 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Application
    - 10.5.8.4.3 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by End User
10.6 South and Central America
- 10.6.1 South and Central America Anatomic Pathology Market Overview
- 10.6.2 South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
- 10.6.3 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Product and Services
- 10.6.4 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Services
- 10.6.5 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Instruments
- 10.6.6 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Application
- 10.6.7 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by End User
- 10.6.8 South and Central America: Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.6.8.1 Brazil: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.8.1.1 Brazil: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.6.8.1.1.1 Brazil: Anatomic Pathology Market Breakdown, by Services
    - 10.6.8.1.1.2 Brazil: Anatomic Pathology Market Breakdown, by Instruments
    - 10.6.8.1.2 Brazil: Anatomic Pathology Market Breakdown, by Application
    - 10.6.8.1.3 Brazil: Anatomic Pathology Market Breakdown, by End User
  - 10.6.8.2 Argentina: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.8.2.1 Argentina: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.6.8.2.1.1 Argentina: Anatomic Pathology Market Breakdown, by Services
    - 10.6.8.2.1.2 Argentina: Anatomic Pathology Market Breakdown, by Instruments
    - 10.6.8.2.2 Argentina: Anatomic Pathology Market Breakdown, by Application
    - 10.6.8.2.3 Argentina: Anatomic Pathology Market Breakdown, by End User
  - 10.6.8.3 Rest of South and Central America: Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.8.3.1 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Product and Services
    - 10.6.8.3.1.1 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Services
    - 10.6.8.3.1.2 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Instruments
    - 10.6.8.3.2 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Application
    - 10.6.8.3.3 Rest of South and Central America: Anatomic Pathology Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Anatomic Pathology Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Beckman Coulter Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Hologic Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Agilent Technologies Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 BioGenex Laboratories Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Diapath S.p.A.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Bio SB
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Merck KGaA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 PHC Holdings Corporation
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms